News
Pulmonary embolisms are more common among children than previous literature has indicated, according to an abstract presented ...
CONSIDERABLE progress has been made in recent years in the understanding of thromboembolic disease and also in the ability to diagnose acute pulmonary embolism. Radiologists have learned to ...
In other patients angiographic and hemodynamic abnormalities persisted weeks after embolism. TO understand the pathophysiology of pulmonary embolic disease, it is necessary to know the rate at ...
According to research, advanced recanalization may increase short-term survival in patients presenting with high-risk PE compared to VA‑ECMO monotherapy.
In a large new study, researchers found an unexpectedly high frequency of pulmonary embolism in pediatric patients - equal to rates seen in adults. It's the first-ever prospective study to look at ...
Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA ...
Internal Jugular, Subclavian, and Axillary Deep Venous Thrombosis and the Risk of Pulmonary Embolism
The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the ...
Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in etiology, share a common trajectory of irreversible lung scarring and ...
Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Personalized Care A nurse practitioner with NYU's pulmonary intervention team chronicles the NSCLC patient experience from diagnosis to ...
CTA, cobbled together from the bankrupt, privately owned surface and elevated systems, was underfunded from day one. The state required the CTA to fund its operations and much of its capital ...
placebo in patients with progressive pulmonary fibrosis, according to results published in The New England Journal of Medicine. This research on oral nerandomilast (BI 1015550, Boehringer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results